Stealth Biotherapeutics Inc. has presented new data demonstrating cardioprotective effects of SBT-589 in preclinical models of Friedreich’s ataxia (FA). SBT-589 acts on mitochondrial pathways ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback